Scarica l'app Stockscreener
73.31
1.34%
0.97
Dopo l'orario di chiusura:
73.45
0.14
+0.19%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LNTH Giù?
Forum
Previsione
Precedente Chiudi:
$72.34
Aprire:
$72.76
Volume 24 ore:
351.28K
Relative Volume:
0.30
Capitalizzazione di mercato:
$5.07B
Reddito:
$1.50B
Utile/perdita netta:
$427.61M
Rapporto P/E:
12.20
EPS:
6.01
Flusso di cassa netto:
$423.98M
1 W Prestazione:
-1.48%
1M Prestazione:
-9.28%
6M Prestazione:
-24.91%
1 anno Prestazione:
-36.54%
Intervallo 1D:
$72.61
$73.39
Intervallo di 1 settimana:
$69.88
$74.98
Portata 52W:
$69.12
$118.21
Lantheus Holdings Inc Stock (LNTH) Company Profile
Nome
Lantheus Holdings Inc
Settore
Telefono
978 671-8001
Indirizzo
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Confronta LNTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
73.31 | 5.00B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
153.45 | 67.31B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.74 | 45.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.75 | 43.35B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.58 | 18.68B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
305.61 | 13.44B | 2.99B | 1.21B | 1.13B | 25.06 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-18 | Iniziato | Goldman | Buy |
| 2024-09-03 | Iniziato | Redburn Atlantic | Buy |
| 2024-07-10 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-12-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Iniziato | TD Cowen | Outperform |
| 2023-09-29 | Iniziato | William Blair | Outperform |
| 2023-03-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-11-30 | Iniziato | SVB Leerink | Outperform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-05-09 | Iniziato | B. Riley Securities | Buy |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2021-02-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-29 | Ripresa | Jefferies | Buy |
| 2019-08-16 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-09-23 | Ripresa | Credit Suisse | Neutral |
| 2016-02-24 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-12-11 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Iniziato | Credit Suisse | Outperform |
| 2015-07-20 | Iniziato | Jefferies | Buy |
| 2015-07-20 | Iniziato | RBC Capital Mkts | Outperform |
| 2015-07-20 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-20 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Lantheus Holdings Inc Borsa (LNTH) Ultime notizie
Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time - The Manila Times
Lantheus Sets Q2 2025 Earnings Call Date: How to Join and What to Expect on August 6 - Stock Titan
Riley Maintains ‘Buy’ Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT - MSN
What analysts say about Lantheus Holdings Inc. stockFree Stock Market Knowledge Sharing - jammulinksnews.com
Lantheus Holdings Inc. Stock Analysis and ForecastExceptional stock performance - jammulinksnews.com
Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet? - 富途牛牛
What drives Lantheus Holdings Inc. stock priceUnbelievable profit margins - jammulinksnews.com
Lantheus Completes Acquisition of Life Molecular Imaging, Names New Head of R&D. - AInvest
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D - The Manila Times
Lantheus Holdings Completes Acquisition of Life Molecular Imaging, Appoints Dr. Ludger Dinkelborg as Head of R&D - Nasdaq
Lantheus Holdings: Forget The Short Term Noise (NASDAQ:LNTH) - Seeking Alpha
Is Lantheus Holdings Inc. a good long term investmentOutstanding investment returns - jammulinksnews.com
Lantheus Holdings Inc Shares Down 3.19% Amidst Analyst Forecasts - AInvest
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know - Yahoo Finance
Lantheus (LNTH): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Lantheus sinks 8% as CMS wants to maintain reimbursement model for radiopharmaceuticals - MSN
Learn to Evaluate (LNTH) using the Charts - news.stocktradersdaily.com
Radiopharmaceutical Renaissance: Lantheus Navigates CMS Policy Shifts to Secure Dominance in Diagnostic Imaging - AInvest
Lantheus Holdings (LNTH) Plunges 14.94% Amid CMS Decision - AInvest
Lantheus Holdings (LNTH) Stock Falls as CMS Retains Current Reim - GuruFocus
Why Is Lantheus Stock Trading Lower On Wednesday? - Benzinga
Why Lantheus (LNTH) Stock Is Down Today - Yahoo Finance
Lantheus (LNTH) Shares Decline Amid Market Activity | LNTH Stock News - GuruFocus
Lantheus Plummets to 52-Week Low: Is the Bottom in Sight or More Pain Ahead? - AInvest
Lantheus Holdings stock reaches 52-week low at $72.92 By Investing.com - Investing.com South Africa
Lantheus Holdings stock reaches 52-week low at $72.92 - Investing.com
Lantheus (LNTH) Likely to Maintain Pylarify Reimbursement Status in 2026 | LNTH Stock News - GuruFocus
Lantheus (LNTH) Faces Setback with CMS Reimbursement Decision | - GuruFocus
Lantheus set to close $750M acquisition of PET agent developer Life Molecular Imaging - Radiology Business
Lantheus Holdings: Navigating Geopolitical Storms to Capture Precision Diagnostics Growth - AInvest
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know - Yahoo Finance
(LNTH) Investment Report - news.stocktradersdaily.com
Lantheus Holdings’ SWOT analysis: theranostics leader faces growth challenges - Investing.com
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2025 Earnings Call Transcript - MSN
Lantheus’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Could The Market Be Wrong About Lantheus Holdings, Inc. (NASDAQ:LNTH) Given Its Attractive Financial Prospects? - 富途牛牛
Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment - MSN
Lantheus Holdings (LNTH): A Breakthrough in Fibrosis Imaging and a Compelling Investment Thesis - AInvest
Lantheus to Present New Oncology Radiodiagnostic Data at SNMMI Meeting - MSN
11 Most Undervalued US Stocks According to Analysts - Insider Monkey
Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & SuppliesImaging, Diagnostics Stocks In Q1 - Yahoo Finance
Alzheimer’s Association Partners with Lantheus for 30th Annual Charity Golf Tournament - The Bedford Citizen
Lantheus at 2025 Truist Securities MedTech Conference: Strategic Growth Path - Investing.com Nigeria
Lantheus at 2025 Truist Securities MedTech Conference: Strategic Growth Path By Investing.com - Investing.com South Africa
(LNTH) Technical Data - news.stocktradersdaily.com
The total return for Lantheus Holdings (NASDAQ:LNTH) investors has risen faster than earnings growth over the last five years - simplywall.st
Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):